Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 49

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 49
---
 of related assets (through one or more 
 related or unrelated transactions), or transfer any interest in any of the Subsidiary to a third party;                                                                                                                                        |

| (O) | (1) not incur or commit to incur any indebtedness for borrowed money, except for the borrowing of working                                                                                                                                           
 capital in connection with the Discontinuance or issue any debt securities, (2) not incur or commit to incur, or guarantee, endorse or otherwise become responsible for, any other material liability, obligation or indemnity or the obligation of 
 any person other than the Subsidiary, or (3) not make any loans or advances to any person other than the Subsidiary;                                                                                                                                |

| (P) | not make any material changes to existing accounting methods, principles, practices or policies or internal 
 controls other than as required by applicable Law or by GAAP;                                               |

- 26 -

| (R) | not engage in any transaction with any related parties other than (i) with the Company and its Subsidiary 
 in connection with the Discontinuance or (ii) in respect of a Permitted Disposition;                      |

| (S) | not commence or settle or assign any rights relating to or any interest in any litigation, proceeding, claim,                                
 action, assessment or investigation that is material to the Company and involving the Company or its Subsidiary or material asset of either; |

| (T) | not waive, release, grant, transfer, exercise, modify or amend in any material respect, other than in                                                                                                                                    
 connection with the Discontinuance, (1) any existing contractual rights in respect of any joint ventures of the Company, (2) any Authorization, lease, concession, contract or other document, or (3) any other material legal rights or 
 claims;                                                                                                                                                                                                                                  |

| (U) | not propose or enter into any agreement, arrangement, commitment, or offer with respect to a material joint 
 venture or other mutual co-operation or distribution agreement;                                             |

| (V) | not enter into any interest rate, currency or equity swaps, hedges, derivatives or other similar financial                                                                                 
 instruments other than (1) in connection with the Discontinuance, (2) if approved by the Board of Directors prior to the date hereof or (3) if required under existing banking facilities; |

| (W) | not increase any coverage under any directors’ and officers’ insurance policy other than as